Investor Relations

Shares Outstanding as of 6/30/09: 2,970,652 common shares
Insider Stock Ownership and Vested Options as of 4/13/09: 28.7%
52-week Trading Range: $1.33 – $4.75
Five-year Trading Range: $1.33 – $9.65

Incorporated: 1982	IPO Date: 1987
Fiscal Year End: December 31	Bank Debt: None
# of Employees: 30	Website: www.immucell.com

ImmuCell is a public biotechnology company that is developing, manufacturing and selling products that improve animal health and productivity in the dairy and beef industries. Our product focus encompasses prevention, diagnosis and treatment of economically important bovine diseases.

Investor Relations:
Michael F. Brigham
President & CEO
ImmuCell Corporation
56 Evergreen Drive
Portland, Maine 04103
207-878-2770
mbrigham@immucell.com

For up-to-date quotes:

• FlashQuote
• Yahoo Finance
• InfoQuote